Microbiological analyses of nasally guided catheters after less invasive surfactant administration - a pilot study

Christian A Maiwald, Julia Dick, Matthias Marschal, Christian Gille, Axel R Franz, Christian F Poets, Christian A Maiwald, Julia Dick, Matthias Marschal, Christian Gille, Axel R Franz, Christian F Poets

Abstract

Background: Respiratory distress syndrome (RDS) is a frequent complication of premature birth. Treating RDS by continuous positive airway pressure and less invasive surfactant administration (LISA) may reduce bronchopulmonary dysplasia. Surfactant, however, can be inactivated by bacterial infection. Therefore, potential routes of microbe transmission into the airway are of interest. The aim of this study was to evaluate microbiological contamination of catheters used for LISA procedures and its association with postnatal age.

Methods: Catheter tips used for LISA procedures via the nasal route (LISA-n) in infants with RDS were placed into a sterile eSwab container directly after the procedure, cultured and examined for microbiological contamination.

Results: Interpretable results could be collected from 20 catheter tips. Four showed positive culture results (20%) with microbes potentially associated with the development of early onset neonatal sepsis. Risk of positive microbe detection increased with postnatal age (< 4 h: 10%; 4-18 h: 20%; > 18 h: 40%).

Conclusions: In this pilot study, the risk of tracheal microbe transmission following the LISA-n procedure increased with postnatal age. Although the clinical relevance of this finding is unclear, earlier surfactant administration might reduce the risk of catheter contamination.

Trial registration number: Substudy of the registered Trial: feasibility study - Neofact: NCT04086095, www.ClinicalTrials.gov, September 11, 2019.

Keywords: LISA; MIST; Neonate; Respiratory distress syndrome; Surfactant administration.

Conflict of interest statement

All contributors declare that they do not have competing interests.

Figures

Fig. 1
Fig. 1
Risk of positive microbiological findings in the selected time periods

References

    1. Lindner W, Vossbeck S, Hummler H, Pohlandt F. Delivery room management of extremely low birth weight infants: spontaneous breathing or intubation? Pediatrics. 1999;103(5 Pt 1):961–967. doi: 10.1542/peds.103.5.961.
    1. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics. 2004;113(6):e560–e563. doi: 10.1542/peds.113.6.e560.
    1. Kribs A, Pillekamp F, Hunseler C, Vierzig A, Roth B. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age </=27 weeks) Paediatr Anaesth. 2007;17(4):364–369. doi: 10.1111/j.1460-9592.2006.02126.x.
    1. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, et al. European consensus guidelines on the Management of Respiratory Distress Syndrome - 2019 update. Neonatology. 2019;115(4):432–450. doi: 10.1159/000499361.
    1. Fabbri L, Klebermass-Schrehof K, Aguar M, Harrison C, Gulczynska E, Santoro D, et al. Five-country manikin study found that neonatologists preferred using the LISAcath rather than the Angiocath for less invasive surfactant administration. Acta paediatrica (Oslo, Norway : 1992). 2018;107(5):780–3.
    1. Maiwald CA, Neuberger P, Vochem M, Poets C. QuickSF: a new technique in surfactant administration. Neonatology. 2016;111(3):211–213. doi: 10.1159/000450823.
    1. Stoll BJ, Hansen NI, Sanchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al. Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues. Pediatrics. 2011;127(5):817–826. doi: 10.1542/peds.2010-2217.
    1. Aly H, Badawy M, Tomerak RH, El-Kholy AA, Hamed AS. Tracheal colonization in preterm infants supported with nasal continuous positive airway pressure. Pediatrics international : official journal of the Japan Pediatric Society. 2012;54(3):356–360. doi: 10.1111/j.1442-200X.2012.03567.x.
    1. Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11:Cd001456.
    1. Canpolat FE, Kadioglu Simsek G, Webbe J, Buyuktiryaki M, Karacaglar NB, Elbayiyev S, et al. Late Administration of Surfactant may Increase the risk of patent Ductus Arteriosus. Front Pediatr. 2020;8:130. doi: 10.3389/fped.2020.00130.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する